Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turner syndrome oxandrolone long-term follow-up study
NL-OMON33605Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxandrolone, somatropin and DehydraTECH-estrogen in Turner syndrome (TS) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Adult height, Body proportions and 10 more. Started Jul 2009; status: active, not recruiting.
02
Drugs
oxandrolonesomatropinDehydraTECH-estrogen
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NL-OMON33605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33605.